Product developments and dissemination activities

This document shows product developments and dissemination activities carried out within the framework of, or in close relation to, the project IEA SHC Task 41; Solar Energy and Architecture. This Task gathered researchers and practicing architects from 14 countries in the three year project whose aim was to identify the obstacles architects are facing when incorporating solar design in their projects, to provide resources for overcoming these barriers and to help improving architects’ communication with other stakeholders in the design of solar buildings. Participating countries were Australia, Austria, Belgium, Canada, Denmark, Germany, Italy, Norway, Portugal, Republic of Korea, Singapore, Spain, Sweden and Switzerland. The report gives not a complete list of activities, but shows the different types of activities to spread the findings in Task 41 and to initiate product developments in participating countries

The communication process

In order to stimulate an increased use of solar in energy conscious building design, the Task 41 participants have developed a Communication Guideline as a tool to support architects in their communication process with especially clients, authorities and contractors. Today the energy performance of solar solutions is well documented and well known especially in the “technical environment”. This knowledge, however, needs to be communicated in a convincing way to the decision makers in order to ensure a broad implementation of sustainable solar solutions in future building design. The Communication Guideline includes convincing arguments and facts supporting the implementation of solar based design solutions. The Communication Guideline is divided in three main parts: • Part 1: Convincing clients to request and commission solar buildings • Part 2: Communication strategies at the design/ construction team level • Part 3: Tools and Reference

Thrombocytopenia and platelet transfusions in ICU patients: an international inception cohort study (PLOT-ICU)

Purpose Thrombocytopenia (platelet count < 150 × 109/L) is common in intensive care unit (ICU) patients and is likely associated with worse outcomes. In this study we present international contemporary data on thrombocytopenia in ICU patients. Methods We conducted a prospective cohort study in adult ICU patients in 52 ICUs across 10 countries. We assessed frequencies of thrombocytopenia, use of platelet transfusions and clinical outcomes including mortality. We evaluated pre-selected potential risk factors for the development of thrombocytopenia during ICU stay and associations between thrombocytopenia at ICU admission and 90-day mortality using pre-specified logistic regression analyses. Results We analysed 1166 ICU patients; the median age was 63 years and 39.5% were female. Overall, 43.2% (95% confidence interval (CI) 40.4–46.1) had thrombocytopenia; 23.4% (20–26) had thrombocytopenia at ICU admission, and 19.8% (17.6–22.2) developed thrombocytopenia during their ICU stay. Non-AIDS-, non-cancer-related immune deficiency, liver failure, male sex, septic shock, and bleeding at ICU admission were associated with the development of thrombocytopenia during ICU stay. Among patients with thrombocytopenia, 22.6% received platelet transfusion(s), and 64.3% of in-ICU transfusions were prophylactic. Patients with thrombocytopenia had higher occurrences of bleeding and death, fewer days alive without the use of life-support, and fewer days alive and out of hospital. Thrombocytopenia at ICU admission was associated with 90-day mortality (adjusted odds ratio 1.7; 95% CI 1.19–2.42). Conclusion Thrombocytopenia occurred in 43% of critically ill patients and was associated with worse outcomes including increased mortality. Platelet transfusions were given to 23% of patients with thrombocytopenia and most were prophylactic.publishedVersio